CBD Pharmaceuticals (a subsidiary of Yuluka Health SAS) Signs Major Long-Term Seed Supply Agreements with Leading European Wholesalers to Start in the 2022 Calendar Year
22 mars 2022 16h51 HE
|
Yuluka Health Inc.
CALI, Colombia, March 22, 2022 (GLOBE NEWSWIRE) -- Yuluka Health SAS is pleased to announce the final stage of completion of its licensing and infrastructure upgrades of its subsidiary CBD...